Literature DB >> 20189212

Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.

Lisa Barrow-Laing1, Wei Chen, Ann Roman.   

Abstract

The E7 protein of high-risk human papillomaviruses (HR HPVs) targets pRb family members (pRb, p107 and p130) for degradation; low-risk (LR) HPV E7 only targets p130 for degradation. The effect of HR HPV 16 E7 and LR HPV 6 E7 on p130 intracellular localization and half-life was examined. Nuclear/cytoplasmic fractionation and immunofluorescence showed that, in contrast to control and HPV 6 E7-expressing cells, a greater amount of p130 was present in the cytoplasm in the presence of HPV 16 E7. The half-life of p130, relative to control cells, was decreased in the cytoplasm in the presence of HPV 6 E7 or HPV 16 E7, but only decreased by HPV 6 E7 in the nucleus. Inhibition of proteasomal degradation extended the half-life of p130, regardless of intracellular localization. These results suggest that there may be divergent mechanisms by which LR and HR HPV E7 target p130 for degradation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189212      PMCID: PMC2861914          DOI: 10.1016/j.virol.2010.01.034

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins.

Authors:  Ernesto Guccione; Paola Massimi; Agnieszka Bernat; Lawrence Banks
Journal:  Virology       Date:  2002-02-01       Impact factor: 3.616

Review 3.  Emerging roles for E2F: beyond the G1/S transition and DNA replication.

Authors:  Hugh Cam; Brian David Dynlacht
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

Review 4.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.

Authors:  K Münger; J R Basile; S Duensing; A Eichten; S L Gonzalez; M Grace; V L Zacny
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

5.  Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism.

Authors:  Anton Chestukhin; Larisa Litovchick; Katherine Rudich; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 6.  Mechanisms of action of flavopiridol.

Authors:  H H Sedlacek
Journal:  Crit Rev Oncol Hematol       Date:  2001-05       Impact factor: 6.312

7.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

Authors:  Donato Tedesco; Jiri Lukas; Steven I Reed
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

Review 8.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

9.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 10.  The retinoblastoma family: twins or distant cousins?

Authors:  Pier Paolo Claudio; Tiziana Tonini; Antonio Giordano
Journal:  Genome Biol       Date:  2002-08-28       Impact factor: 13.583

View more
  15 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 2.  Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

3.  Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis.

Authors:  Giulia Naldini; Chiara Grisci; Manuela Chiavarini; Roberto Fabiani
Journal:  Int J Public Health       Date:  2019-06-08       Impact factor: 3.380

Review 4.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

Review 5.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

Review 6.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

7.  Localisation of human papillomavirus 16 E7 oncoprotein changes with cell confluence.

Authors:  Joanna Laurson; Kenneth Raj
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

Review 8.  Human papillomavirus molecular biology and disease association.

Authors:  John Doorbar; Nagayasu Egawa; Heather Griffin; Christian Kranjec; Isao Murakami
Journal:  Rev Med Virol       Date:  2015-03       Impact factor: 6.989

Review 9.  Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.

Authors:  Cary Moody
Journal:  Viruses       Date:  2017-09-19       Impact factor: 5.048

10.  Assessing parallel gene histories in viral genomes.

Authors:  Beatriz Mengual-Chuliá; Stéphanie Bedhomme; Guillaume Lafforgue; Santiago F Elena; Ignacio G Bravo
Journal:  BMC Evol Biol       Date:  2016-02-05       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.